Predicting the duration of supplemental home oxygen in prematurely-born infants at discharge from neonatal care.


Journal

Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381

Informations de publication

Date de publication:
06 2021
Historique:
received: 05 02 2021
revised: 05 03 2021
accepted: 09 03 2021
pubmed: 10 4 2021
medline: 15 12 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

Discharge home of preterm infants on supplemental oxygen has significant healthcare, parental psychological and financial implications, but the potential ability of clinical parameters at discharge to predict the duration of home oxygen has not been previously examined. To use clinical and epidemiological parameters available at discharge to predict the duration of home oxygen therapy. Retrospective observational cohort study with a primary and a validation cohort. Seventy one infants born <32 completed weeks of gestational age, born between 1/1/2013-1/1/2020 at King's College Hospital NHS Foundation trust and discharged home on supplemental oxygen were studied. Duration of home oxygen therapy. In a primary cohort of 52 infants with a median (IQR) gestational age of 26.4 (25.0-28.1) weeks and birth weight of 0.81 (0.69-0.96) kg, the duration of home oxygen was four (3-7) months (range: 1-22 months). The postmenstrual age (adjusted p = 0.001) and oxygen flow at discharge (adjusted p = 0.046) were independently associated with the duration of home oxygen therapy. In a validation cohort of 19 infants, the correlation coefficient between the calculated and the observed duration of home oxygen was 0.62, p = 0.005 and the coefficient of determination was 0.38. Infants discharged home on higher oxygen flows and at a greater postmenstrual age require a longer duration of home oxygen therapy and these parameters can be used to predict the duration of home oxygen therapy.

Sections du résumé

BACKGROUND
Discharge home of preterm infants on supplemental oxygen has significant healthcare, parental psychological and financial implications, but the potential ability of clinical parameters at discharge to predict the duration of home oxygen has not been previously examined.
AIMS
To use clinical and epidemiological parameters available at discharge to predict the duration of home oxygen therapy.
STUDY DESIGN
Retrospective observational cohort study with a primary and a validation cohort.
SUBJECTS
Seventy one infants born <32 completed weeks of gestational age, born between 1/1/2013-1/1/2020 at King's College Hospital NHS Foundation trust and discharged home on supplemental oxygen were studied.
OUTCOME MEASURE
Duration of home oxygen therapy.
RESULTS
In a primary cohort of 52 infants with a median (IQR) gestational age of 26.4 (25.0-28.1) weeks and birth weight of 0.81 (0.69-0.96) kg, the duration of home oxygen was four (3-7) months (range: 1-22 months). The postmenstrual age (adjusted p = 0.001) and oxygen flow at discharge (adjusted p = 0.046) were independently associated with the duration of home oxygen therapy. In a validation cohort of 19 infants, the correlation coefficient between the calculated and the observed duration of home oxygen was 0.62, p = 0.005 and the coefficient of determination was 0.38.
CONCLUSIONS
Infants discharged home on higher oxygen flows and at a greater postmenstrual age require a longer duration of home oxygen therapy and these parameters can be used to predict the duration of home oxygen therapy.

Identifiants

pubmed: 33836487
pii: S0378-3782(21)00052-9
doi: 10.1016/j.earlhumdev.2021.105353
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105353

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Sophia Teoh (S)

Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Ravindra Bhat (R)

Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Anne Greenough (A)

Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United Kingdom; NIHR Biomedical Centre at Guy's and St Thomas NHS Foundation Trust and King's College London, London, United Kingdom.

Theodore Dassios (T)

Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom; Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. Electronic address: theodore.dassios@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH